Harvard Researchers Warn AI Health Tools Are Leaving Vulnerable Patients Behind
A New England Journal of Medicine perspective argues that healthcare AI risks deepening inequities for underserved populations.
562 articles in this topic
A New England Journal of Medicine perspective argues that healthcare AI risks deepening inequities for underserved populations.
A NEJM perspective piece explores the hidden meaning and emotional depth found in everyday clinical encounters.
A cerebral syphilitic gumma case published in NEJM reminds clinicians that neurosyphilis can mimic brain tumors and must stay on the differential.
New research links somatic DNA variants in microglia-like cells to Alzheimer's pathology, opening a novel genetic avenue for disease intervention.
A major Nature Reviews Nephrology analysis reveals uremic toxins, BBB breakdown, and glymphatic failure drive cognitive decline in CKD patients.
After ischemic stroke, a mislocated brain water channel (AQP4) disrupts waste clearance. Blocking AQP4 with TGN-020 corrects its position and restores glymphatic flow.
New review reveals how glymphatic and meningeal lymphatic dysfunction drive Aβ and tau buildup, and how sleep, surgery, and genetics factor in.
Deleting or inhibiting astrocytic PERK restores the brain's glymphatic drainage system and dramatically reduces Aβ and tau pathology in AD mouse models.
A landmark review proposes a paradigm shift in neurocritical care, moving from static ICP thresholds to dynamic intracranial monitoring of autoregulation, glymphatics, and compliance.
A cohort study reveals people with functional neurological disorder face a distinct and heavy comorbidity profile compared to epilepsy and MS patients.
New research links age at Parkinson's onset and family history to the likelihood of carrying disease-causing genetic variants.
A major meta-analysis reveals DLB incidence rises steeply with age and is higher in men, but widespread underdiagnosis distorts true burden.